SP

Seema Pandey

Active Director Director DIN 07292238
DIN 07292238 First appointment Nov 2015 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value •••• Premium profile

About Seema Pandey

Data last updated:

Seema Pandey is a Director at Prelude Pharmaceuticals Private Limited (since 2015). The company operates in Professional Services. Prelude Pharmaceuticals Private Limited reported revenue of ₹26,220 (FY 2024).

DIN 07292238
Primary Designation Director
Industry Professional Services
First Appointment 18 Nov 2015
Oldest Company Age 10 yrs
Largest company Prelude Pharmaceuticals Private Limited · ₹26,220 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Nov 20152015₹26,220 (FY 2024)Active

Board colleagues of Seema Pandey

Directorship timeline

Open interactive timeline →
Prelude Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Seema Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Pandey

Seema Pandey currently holds 1 directorship: Prelude Pharmaceuticals Private Limited (Director, since 18 Nov 2015, revenue ₹26,220 (FY 2024)).

Seema Pandey was first appointed on 18 Nov 2015 as Director at Prelude Pharmaceuticals Private Limited.

The current boards of Seema Pandey's companies include Savita Pandey (Prelude Pharmaceuticals Private Limited), Shubhang Pandey (Prelude Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available